Healthcare: This is Absolutely The Best Biotech Stock To Buy Right Now

<p><span style="font-family: Calibri, Arial, Helvetica, sans-serif; font-size: 16px; line-height: 24px;">A drop dead, massively big, upside opportunity exists for this pre-clinical stage biotech star. Motley Fool analyst Michael Douglass and contributor Todd Campbell discuss this and much more.</span></p>